...
首页> 外文期刊>Human psychopharmacology: clinical and experimental >Factors influencing lithium pharmacokinetics in patients with acute mania: A population pharmacokinetic analysis
【24h】

Factors influencing lithium pharmacokinetics in patients with acute mania: A population pharmacokinetic analysis

机译:影响急性躁狂症患者锂药代动力学的因素:人群药代动力学分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Objective The objective of this study was to conduct a population pharmacokinetic model of lithium in Thai patients with acute mania. Methods Lithium concentrations from 222 acute manic patients were included in this study. The population pharmacokinetic model was developed using NONMEM 7.3 software. Influences of potential covariates including body size, age, renal function, and gender were evaluated through a?stepwise approach. Bootstrap analysis and an external validation approach were used to evaluate the robustness and predictability of the final model. Results A one‐compartment model adequately described lithium pharmacokinetics. Body weight and age were significant predictors for lithium clearance, with the following relationship: CL/F (L/hr)?=?1.43?*?(WT/65) 0.425 ?*?(age/38) ?0.242 . The population estimates of lithium clearance, volume of distribution, and absorption rate constant of the final model were 1.43?L/hr, 54?L (fixed), and 0.426?hr ?1 (fixed), respectively. Model evaluation showed that the final model was predictive and robust. Conclusions A population pharmacokinetic model of lithium with good performance was developed in Thai patients with acute mania. This model can be used to assist clinicians in individualized lithium therapy.
机译:摘要目的本研究的目的是在急性躁狂症患者中进行锂锂的人口药代动力学模型。方法本研究纳入222例急性躁狂症患者的锂浓度。使用非梅尔7.3软件开发了人口药代动力学模型。通过A逐步的方法评估潜在的协变量,包括体积,年龄,肾功能和性别,包括体积,年龄,肾功能和性别。 Bootstrap分析和外部验证方法用于评估最终模型的鲁棒性和可预测性。结果一室模型适当描述锂药代动力学。体重和年龄是锂清除的重要预测因子,具有以下关系:Cl / F(L / Hr)?=?1.43?*?(WT / 65)0.425?*(年龄/ 38)?0.242。最终模型的锂间隙,分布体积和吸收率常数的人口估计分别为1.43Ω·l / hr,54μl(固定),分别为0.426?1(固定)。模型评估表明,最终模型是预测和鲁棒的。结论在急性躁狂症患者中开发了良好表现锂锂锂的人口药代动力学模型。该模型可用于帮助临床医生在个性化锂疗法中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号